US Stocks
/
Seres Therapeutics, Inc. Share Price

Seres Therapeutics, Inc. Share Price

NASDAQ: MCRB | Micro Cap
$2.71
+$0.07 (2.65%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Seres Therapeutics, Inc. Stock Performance

Open
$2.64
Prev. Close
$2.64
Circuit Range
N/A
Day Range
$2.64 - $2.73
Year Range
$2.43 - $29.59
Volume
2,994
Average Traded
$2.70

Seres Therapeutics, Inc. Share Price Today

As of 11 October 2026, Seres Therapeutics, Inc.'s share price is $2.71. The stock opened at $2.64, compared to its previous close of $2.64. During today's trading session, Seres Therapeutics, Inc.'s share price traded between $2.64 and $2.73, with an average price of $2.69. Over the past 52 weeks, the stock has recorded a high of $29.59 and a low of $2.43. In terms of performance, Seres Therapeutics, Inc.'s share price has declined by 63.53% over the last six months and is down 83.48% on a year-on-year basis.

Seres Therapeutics, Inc. Share Price Chart

$2.64$2.73
L
Show Current Price
H

Seres Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$24.01M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.24
Revenue (TTM)
$790.00M
Return On Equity (TTM)
-65.05%
Profit Margin
721.52%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-44.15%

Seres Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.35$0.44$0.36$0.74
Net Profit$8.20-$15.34-$19.91$4.58
Net Profit Margin2342.86%-3486.36%-5530.56%618.92%
Income ChangeN/A-287.07%-29.79%123.00%

Seres Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.79
Net Profit-$250.16-$113.72$0.14$5.70
Net Profit MarginN/AN/AN/A721.52%
Income ChangeN/A54.54%100.12%3971.43%

About Seres Therapeutics, Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Seres Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$3.19
$2.72
-19.29%
Sep 2026
$4.96
$3.37
-32.33%
Aug 2026
$4.97
$4.98
+5.06%
Jul 2026
$7.76
$4.74
-39.85%
Jun 2026
$7.39
$7.88
+6.92%
May 2026
$7.45
$7.37
-0.81%
Apr 2026
$9.20
$7.43
-16.52%
Mar 2026
$8.89
$8.90
+1.71%
Feb 2026
$15.00
$8.75
-40.58%
Jan 2026
$14.99
$14.72
-0.77%
Dec 2025
$18.05
$14.84
-17.74%
Nov 2025
$16.38
$18.04
+10.00%

MCRB Share Price FAQs

What is Seres Therapeutics, Inc. share price today?

chevron-up
Seres Therapeutics, Inc. share price today is $2.71 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Seres Therapeutics, Inc. stock?

chevron-up
The 52 week high of Seres Therapeutics, Inc. stock is $29.59, while the 52 week low is $2.43 as of 10 Oct '26.

What is MCRB's market capitalisation today?

chevron-up
MCRB market capitalisation is $24.01M as of October 11, 2026, at 2:06 am IST.

What is MCRB's net income for the last quarter?

chevron-up
MCRB's net income for the last quarter is 4.58B USD.

What is the 5 year returns of MCRB?

chevron-up
The 5 year returns of MCRB is -97.77% as on 10 Oct '26.

What is the high & low stock price of MCRB today?

chevron-up
MCRB stock price hit a high of $2.73 and low of $2.64 as of 10 Oct '26.

Can I buy MCRB shares in India?

chevron-up
Yes. You can buy MCRB in India by opening an international trading account.